Clinical trial vials

Clinical trial vials store experimental drugs, adhering to strict safety and traceability standards.

About this subject

Clinical trial vials are primary containers for investigational drugs, typically made of Type I borosilicate glass to ensure chemical inertness and contamination protection. Each vial carries a unique label with barcode, batch number, expiry date, and participant ID, enabling traceability in double-blind randomized studies.

Regulatory agencies like the FDA and EMA require strict adherence to Good Manufacturing Practices (GMP). Vials undergo washing with water for injection and steam sterilization before filling. Temperature control between 2°C and 8°C is common for biologics, with amber glass used for light-sensitive compounds.

Volumes range from 2 to 50 mL, sealed with aluminum crimp caps and butyl rubber stoppers. Each vial may contain placebo, single dose, or multi-dose formulations. Clear vials allow visual inspection for particles, a critical quality check.

The standardization of clinical trial vials emerged in the early 20th century, greatly enhancing trial precision. Major research institutions like the NIH and global vaccine manufacturers produce millions of these vials annually.

Frequently Asked Questions

Why are clinical trial vials made of borosilicate glass?

Type I borosilicate glass provides chemical and thermal resistance, preventing reactions with the drug and withstanding autoclave sterilization.

How is traceability ensured for clinical trial vials?

Each vial receives a unique barcode with batch number, expiry date, and participant ID, linked to the trial's electronic system.

What is the difference between single-dose and multi-dose vials?

Single-dose vials contain volume for one administration and must be discarded after use. Multi-dose vials include preservatives and allow multiple withdrawals with a sterile needle.